🇺🇸 FDA
Pipeline program

DMT in healthy subjects

CHDR2227

Phase 1 other active

Quick answer

DMT in healthy subjects for Stroke is a Phase 1 program (other) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Lacuna Pharma Pty Ltd
Indication
Stroke
Phase
Phase 1
Modality
other
Status
active

Clinical trials